153 related articles for article (PubMed ID: 36259863)
21. A case of generalized discoid lupus erythematosus: successful treatment with imiquimod cream 5%.
Gül U; Gönül M; Cakmak SK; Kiliç A; Demiriz M
Adv Ther; 2006; 23(5):787-92. PubMed ID: 17142214
[TBL] [Abstract][Full Text] [Related]
22. Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face.
Diluvio L; Campione E; Paternò EJ; Orlandi A; Terrinoni A; Chimenti S
J Dermatolog Treat; 2009; 20(2):124-9. PubMed ID: 18991155
[TBL] [Abstract][Full Text] [Related]
23. Imiquimod: in superficial basal cell carcinoma.
Oldfield V; Keating GM; Perry CM
Am J Clin Dermatol; 2005; 6(3):195-200; discussion 201-2. PubMed ID: 15943496
[TBL] [Abstract][Full Text] [Related]
24. Lupus erythematosus-like imiquimod reaction: a diagnostic pitfall.
Barr KL; Konia TH; Fung MA
J Cutan Pathol; 2011 Apr; 38(4):346-50. PubMed ID: 20726930
[TBL] [Abstract][Full Text] [Related]
25. Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma.
Bostanci S; Kocyigit P; Vural S; Heper AO; Botsali A
Dermatol Surg; 2018 Jan; 44(1):36-41. PubMed ID: 29016542
[TBL] [Abstract][Full Text] [Related]
26. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
[TBL] [Abstract][Full Text] [Related]
27. Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma.
Sriprakash K; Godbolt A
Australas J Dermatol; 2009 Aug; 50(3):211-3. PubMed ID: 19659986
[TBL] [Abstract][Full Text] [Related]
28. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.
Peris K; Campione E; Micantonio T; Marulli GC; Fargnoli MC; Chimenti S
Dermatol Surg; 2005 Mar; 31(3):318-23. PubMed ID: 15841634
[TBL] [Abstract][Full Text] [Related]
29. A preliminary study of imiquimod treatment in variants of basal cell carcinoma.
McCutcheon B; White K; Kotwall C; Germolic D; Rebolloso Y; Hamann MS; Stiles A
Am Surg; 2005 Aug; 71(8):662-5. PubMed ID: 16217949
[TBL] [Abstract][Full Text] [Related]
30. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series.
Huber A; Huber JD; Skinner RB; Kuwahara RT; Haque R; Amonette RA
Dermatol Surg; 2004 Mar; 30(3):429-30. PubMed ID: 15008876
[TBL] [Abstract][Full Text] [Related]
31. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
Akkilic-Materna M; Massone C; Komericki P
Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
[TBL] [Abstract][Full Text] [Related]
32. Visualization and treatment of subclinical actinic keratoses with topical imiquimod 5% cream: an observational study.
Kopera D; Kerl H
Biomed Res Int; 2014; 2014():135916. PubMed ID: 24900953
[TBL] [Abstract][Full Text] [Related]
33. 5% topical imiquimod tolerance in transplant recipients.
Ben M'barek L; Mebazaa A; Euvrard S; Frances C; Thervet E; Morel P; Menasché S; Legendre C; Lebbe C
Dermatology; 2007; 215(2):130-3. PubMed ID: 17684375
[TBL] [Abstract][Full Text] [Related]
34. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
35. Eruptive epidermoid cysts resulting from treatment with imiquimod.
Marty CL; Randle HW; Walsh JS
Dermatol Surg; 2005 Jul; 31(7 Pt 1):780-2; discussion 782-3. PubMed ID: 16029707
[TBL] [Abstract][Full Text] [Related]
36. The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview.
Stockfleth E; Trefzer U; Garcia-Bartels C; Wegner T; Schmook T; Sterry W
Br J Dermatol; 2003 Nov; 149 Suppl 66():53-6. PubMed ID: 14616352
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature.
Drehs MM; Cook-Bolden F; Tanzi EL; Weinberg JM
Dermatol Surg; 2002 May; 28(5):427-9. PubMed ID: 12030878
[TBL] [Abstract][Full Text] [Related]
38. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream.
Cowen E; Mercurio MG; Gaspari AA
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S240-8. PubMed ID: 12271286
[TBL] [Abstract][Full Text] [Related]
39. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
40. Basal cell carcinoma: treatment with imiquimod.
Bukhardt Pérez MP; Ruiz-Villaverde R; Naranjo Díaz MJ; Blasco Melguizo J; Naranjo Sintes R
Int J Dermatol; 2007 May; 46(5):539-42. PubMed ID: 17472691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
